Literature DB >> 2559720

Neurotensin stimulates inositol trisphosphate-mediated calcium mobilization but not protein kinase C activation in HT29 cells. Involvement of a G-protein.

J C Bozou1, N Rochet, I Magnaldo, J P Vincent, P Kitabgi.   

Abstract

It has previously been shown that neurotensin binds to high-affinity receptors in the adenocarcinoma HT29 cell line, and that receptor occupancy leads to inositol phosphate formation. The present study was designed to investigate further the effects of neurotensin on calcium mobilization and protein kinase C (PKC) activation in HT29 cells, and to assess the role of GTP-binding proteins (G-proteins) in the neurotensin response. Direct measurements of cytosolic Ca2+ variations using the fluorescent indicator quin 2 showed that neurotensin (0.1-1 microM) elicited Ca2+ transients in HT29 cells. These transients occurred after the neurotensin-stimulated formation of Ins(1,4,5)P3, as measured by means of a specific radioreceptor assay. In addition, the peptide induced a decrease in the 45Ca2+ content of cells previously equilibrated with this isotope. The peptide effect was rapid, long-lasting and concentration-dependent, with an EC50 of 2 nM. Phorbol 12-myristate 13-acetate (PMA) inhibited by 50% the neurotensin effects on both intracellular Ca2+ and inositol phosphate levels. The inhibition by PMA was abolished in PKC-depleted cells. Pertussis toxin had no effect on either the Ca2+ or inositol phosphate responses to neurotensin. Epidermal growth factor (EGF) receptors which are present in HT29 cells have been shown to be down-regulated through phosphorylation by PKC in a variety of systems. Here, PMA markedly (70-80%) inhibited EGF binding to HT29 cells. Scatchard analysis revealed that PMA abolished the high-affinity component of EGF binding, an effect that was totally reversed in PKC-depleted cells. In contrast, neurotensin slightly (10-20%) inhibited EGF binding to HT29 cells, and its effect was only partly reversed by PKC depletion. Neurotensin had no detectable effect on sn-1,2-diacylglycerol levels in HT29 cells, as measured by a specific and sensitive enzymic assay. In membranes prepared from HT29 cells, monoiodo[125I-Tyr3]neurotensin bound to a single population of receptors with a dissociation constant of 0.27 nM. Sodium and GTP inhibited neurotensin binding in a concentration-dependent manner. Maximal inhibition reached 80% with Na+ and 35% with GTP.IC50 values were 20 mM and 0.2 microM for Na+ and GTP respectively. Li+ and K+ were less effective than Na+ and the effects of GTP were shared by GDP and guanosine-5'-[beta gamma- imido]triphosphate but not by ATP. Scatchard analysis of binding data indicated that Na+ and GTP converted the high-affinity neurotensin-binding sites into lower affinity binding sites. The properties of the effects of Na+ and GTP on neurotensin-receptor interactions are characteristic of those receptors which interact with G-proteins.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2559720      PMCID: PMC1133666          DOI: 10.1042/bj2640871

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  The agonist-sensitive calcium pool in the pancreatic acinar cell. Activation of plasma membrane Ca2+ influx mechanism.

Authors:  S J Pandol; M S Schoeffield; C J Fimmel; S Muallem
Journal:  J Biol Chem       Date:  1987-12-15       Impact factor: 5.157

Review 2.  Inositol trisphosphate and diacylglycerol as second messengers.

Authors:  M J Berridge
Journal:  Biochem J       Date:  1984-06-01       Impact factor: 3.857

3.  Reduction of epidermal growth factor receptor affinity by heterologous ligands: evidence for a mechanism involving the breakdown of phosphoinositides and the activation of protein kinase C.

Authors:  K D Brown; J Blay; R F Irvine; J P Heslop; M J Berridge
Journal:  Biochem Biophys Res Commun       Date:  1984-08-30       Impact factor: 3.575

4.  Insulin and glucagon receptors of isolated rat hepatocytes: comparison between hormone binding and amino acid transport stimulation.

Authors:  M Fehlmann; O Morin; P Kitabgi; P Freychet
Journal:  Endocrinology       Date:  1981-07       Impact factor: 4.736

5.  Effects of neurotensin on intestinal smooth muscle: application to the study of structure-activity relationships.

Authors:  P Kitabgi
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

6.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

7.  Vasopressin rapidly stimulates Ca2+ efflux from intracellular pool in quiescent Swiss 3T3 cells.

Authors:  A Lopez-Rivas; E Rozengurt
Journal:  Am J Physiol       Date:  1984-09

8.  Preparation of neurotensin selectively iodinated on the tyrosine 3 residue. Biological activity and binding properties on mammalian neurotensin receptors.

Authors:  J L Sadoul; J Mazella; S Amar; P Kitabgi; J P Vincent
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

9.  Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacylglycerol intermediate.

Authors:  S M Prescott; P W Majerus
Journal:  J Biol Chem       Date:  1983-01-25       Impact factor: 5.157

10.  Neurotensin stimulates inositol phospholipid hydrolysis in rat brain slices.

Authors:  M Goedert; R D Pinnock; C P Downes; P W Mantyh; P C Emson
Journal:  Brain Res       Date:  1984-12-03       Impact factor: 3.252

View more
  22 in total

1.  Transmitter-induced changes of the membrane voltage of HT29 cells.

Authors:  E Lohrmann; Z I Cabantchik; R Greger
Journal:  Pflugers Arch       Date:  1992-06       Impact factor: 3.657

2.  The rotavirus enterotoxin NSP4 mobilizes intracellular calcium in human intestinal cells by stimulating phospholipase C-mediated inositol 1,4,5-trisphosphate production.

Authors:  Y Dong; C Q Zeng; J M Ball; M K Estes; A P Morris
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: activation of signal transduction pathways and perturbations of intestinal absorption and secretion.

Authors:  J Fantini; M Maresca; D Hammache; N Yahi; O Delézay
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

4.  Signal transduction pathways mediating mucin secretion from intestinal goblet cells.

Authors:  T E Phillips; J Wilson
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

5.  Characterization of high affinity neurotensin receptor NTR1 in HL-60 cells and its down regulation during granulocytic differentiation.

Authors:  S Y Choi; H D Chae; T J Park; H Ha; K T Kim
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

Review 6.  Neurotensin receptors: binding properties, transduction pathways, and structure.

Authors:  J P Vincent
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

7.  Role of calcium in carbachol- and neurotensin-induced mucin exocytosis in a human colonic goblet cell line and cross-talk with the cyclic AMP pathway.

Authors:  C Bou-Hanna; B Berthon; L Combettes; M Claret; C L Laboisse
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

8.  Agonist-induced intracellular Ca2+ transients in HT29 cells.

Authors:  R Nitschke; J Leipziger; R Greger
Journal:  Pflugers Arch       Date:  1993-06       Impact factor: 3.657

9.  Characterization of the effect of SR48692 on inositol monophosphate, cyclic GMP and cyclic AMP responses linked to neurotensin receptor activation in neuronal and non-neuronal cells.

Authors:  F Oury-Donat; O Thurneyssen; N Gonalons; P Forgez; D Gully; G Le Fur; P Soubrie
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

10.  Neurotensin expression and release in human colon cancers.

Authors:  B M Evers; J Ishizuka; D H Chung; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1992-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.